Диссертация (1174200), страница 52
Текст из файла (страница 52)
63. – № 16.– P. 1675-1683.259. Nagamalesh U.M. Acute pulmonary thromboembolism: Epidemiology, predictors,and long-term outcome–A single center experience / U.M. Nagamalesh [et al.] //Indian heart journal. – 2017. – Т. 69. – № 2. – P. 160-164.260. Nakamura M. Current venous thromboembolism management and outcomes inJapan / M. Nakamura [et al.] // Circulation Journal. – 2014. – Т. 78. – № 3. –P.
708-717.261. Nazzal M. Complications related to inferior vena cava filters: a single-centerexperience / M. Nazzal [et al.] // Annals of vascular surgery. – 2010. – Т. 24. –№ 4. – P. 480-486.262. Nicholson W. Prevalence of fracture and fragment embolization of Bardretrievable vena cava filters and clinical implications including cardiac perforationand tamponade / W. Nicholson [et al.] // Archives of internal medicine. – 2010. –Т. 170. – № 20.
– P. 1827-1831.263. Nieto J.A. Fatal bleeding in patients receiving anticoagulant therapy for venousthromboembolism: findings from the RIETE registry / J.A. Nieto [et al.] // Journalof Thrombosis and Haemostasis. – 2010. – Т. 8. – № 6. – P. 1216-1222.264. Nishizawa J. A surgical case of acute massive pulmonary embolism associatedwith a giant free-floating inferior vena cava thrombus / J. Nishizawa, A. Yamazato,C. Park // Kyobu geka.
The Japanese journal of thoracic surgery. – 2000. – Т. 53. –№ 10. – P. 874-876.313265. Norris C.S. Free-floating iliofemoral thrombus: a risk of pulmonary embolism /C.S. Norris, L.J. Greenfield, J.B. Herrmann // Archives of Surgery. – 1985. –Т. 120. – № 7. – P. 806-808.266. O’Connor D.J. Incidence and characteristics of venous thromboembolic diseaseduring pregnancy and the postnatal period: a contemporary series / D.J. O’Connor[et al.] // Annals of vascular surgery. – 2011. – Т.
25. – № 1. – P. 9-14.267. Oguzkurt L. Endovascular treatment of phlegmasia cerulea dolens with impendingvenous gangrene: manual aspiration thrombectomy as the first-line thrombusremoval method / L. Oguzkurt [et al.] // Cardiovascular and interventionalradiology. – 2011. – Т. 34. – № 6. – P. 1214-1221.268. Ost D. Duration of anticoagulation following venous thromboembolism: a metaanalysis / D.
Ost [et al.] // Jama. – 2005. – Т. 294. – № 6. – P. 706-715.269. Otero R. Echocardiographic assessment of pulmonary arterial pressure in thefollow-up of patients with pulmonary embolism / R. Otero [et al.] // Thrombosisresearch. – 2011. – Т. 127. – № 4. – P. 303-308.270. Ozturk C. Efficacy of prophylactic placement of inferior vena cava filter in patientsundergoing spinal surgery / C.
Ozturk [et al.] // Spine. – 2010. – Т. 35. – № 20. –P. 1893-1896.271. Pacouret G. Free-floating thrombus and embolic risk in patients withangiographically confirmed proximal deep venous thrombosis: a prospective study/ G. Pacouret [et al.] // Archives of internal medicine. – 1997. – Т. 157.
– № 3. –P. 305-308.272. Palareti G. D-dimer testing to determine the duration of anticoagulation therapy /G. Palareti [et al.] // New England Journal of Medicine. – 2006. – Т. 355. – № 17.– P. 1780-1789.273. Palareti G. D-dimer to guide the duration of anticoagulation in patients withvenous thromboembolism: a management study / G. Palareti [et al.] // Blood. –2014. – Т. 124. – № 2. – P. 196-203.314274. Pan Y. Retrievable inferior vena cava filters in trauma patients: prevalence andmanagement of thrombus within the filter / Y.
Pan [et al.] // European Journal ofVascular and Endovascular Surgery. – 2016. – Т. 52. – № 6. – P. 830-837.275. Park B. Recent trends in clinical outcomes and resource utilization for pulmonaryembolism in the United States: findings from the nationwide inpatient sample / B.Park [et al.] // Chest. – 2009. – Т. 136. – № 4. – P.
983-990.276. Pengo V. Incidence of chronic thromboembolic pulmonary hypertension afterpulmonary embolism / V. Pengo [et al.] // New England Journal of Medicine. –2004. – Т. 350. – № 22. – P. 2257-2264.277. Pernod G. French clinical practice guidelines on the management of patients onvitamin K antagonists in at-risk situations (overdose, risk of bleeding, and activebleeding) / G. Pernod [et al.] // Thrombosis research. – 2010. – Т.
126. – № 3. –P. 167-174.278. Piazza G. Submassive pulmonary embolism / G. Piazza // JAMA. – 2013. – Т. 309.– № 2. – P. 171-180.279. Plate G. Long-term results of venous thrombectomy combined with a temporaryarterio-venous fistula / G.
Plate [et al.] // European journal of vascular surgery. –1990. – Т. 4. – № 5. – P. 483-489.280. Plate G. Venous thrombectomy for lliofemoral vein thrombosis—10-year results ofa prospective randomised study / G. Plate [et al.] // European journal of vascularand endovascular surgery. – 1997. – Т. 14. – № 5. – P. 367-374.281. Poli D.
Incidence of recurrent venous thromboembolism and of chronicthromboembolic pulmonary hypertension in patients after a first episode ofpulmonary embolism / D. Poli [et al.] // Journal of thrombosis and thrombolysis. –2010. – Т. 30. – № 3. – P. 294-299.282. Ponomar E. Clot-trapper device for transjugular thrombectomy from the inferiorvena cava. / E. Ponomar [et al.] // Radiology.
– 1991. – Т. 179. – № 1. – P. 279282.283. Powers P.J. A randomized trial of less intense postoperative warfarin or aspirintherapy in the prevention of venous thromboembolism after surgery for fractured315hip / P.J. Powers [et al.] // Archives of internal medicine. – 1989. – Т. 149. – № 4.– P. 771-774.284. Prandoni P. Recurrent venous thromboembolism and bleeding complicationsduring anticoagulant treatment in patients with cancer and venous thrombosis / P.Prandoni [et al.] // Blood.
– 2002. – Т. 100. – № 10. – P. 3484-3488.285. Prandoni P. The risk of recurrent venous thromboembolism after discontinuinganticoagulation in patients with acute proximal deep vein thrombosis or pulmonaryembolism. A prospective cohort study in 1,626 patients / P. Prandoni [et al.] //Haematologica. – 2007. – Т. 92. – № 2. – P. 199-205.286. Prandoni P. Major bleeding as a predictor of mortality in patients with venousthromboembolism: findings from the RIETE Registry. / P. Prandoni [et al.] //Journal of thrombosis and haemostasis: JTH. – 2010. – Т. 8. – № 11.
– P. 25752577.287. Prandoni P. Post‐thrombotic syndrome: prevalence, prognostication and need forprogress / P. Prandoni, S.R. Kahn // British journal of haematology. – 2009. –Т. 145. – № 3. – P. 286-295.288. Prins M.H. Oral rivaroxaban versus standard therapy for the treatment ofsymptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVTand PE randomized studies / M.H.
Prins [et al.] // Thrombosis journal. – 2013. –Т. 11. – № 1. – P. 21.289. Rajasekhar A. Vena cava filters for management of venous thromboembolism: aclinical review / A. Rajasekhar, M.B. Streiff // Blood reviews. – 2013. – Т. 27. –№ 5. – P. 225-241.290. Randelli F. II Italian intersociety consensus statement on antithromboticprophylaxis in orthopaedics and traumatology / F. Randelli [et al.] // Journal ofOrthopaedics and Traumatology.
– 2013. – Т. 14. – № 1. – P. 1-13.291. Raskob G. The Hokusai VTEi. Edoxaban for the long-term treatment of venousthromboembolism: rationale and design of the Hokusai-VTE study / G. Raskob [etal.] // J Thromb Haemost. – 2013. – Т. 11. – № 7. – P. 1287-1294.316292. Raskob G.E. Edoxaban for the treatment of cancer-associated venousthromboembolism / G.E. Raskob [et al.] // New England Journal of Medicine.
–2018. – Т. 378. – № 7. – P. 615-624.293. Ravitch M.M. Compartmentation of the vena cava with the mechanical stapler. /M.M. Ravitch [et al.] // Surgery, gynecology & obstetrics. – 1966. – Т. 122. – № 3.– P. 561-566.294. Reddy S. Association between contemporary trends in inferior vena cava filterplacement and the 2010 US Food and Drug Administration advisory / S. Reddy [etal.] // JAMA internal medicine. – 2017. – Т.
177. – № 9. – P. 1373-1374.295. Ridker P.M. Long-term, low-intensity warfarin therapy for the prevention ofrecurrent venous thromboembolism / P.M. Ridker [et al.] // New England Journalof Medicine. – 2003. – Т. 348. – № 15. – P. 1425-1434.296. Righini M., Righini M. Approach to suspected acute pulmonary embolism: shouldwe use scoring systems? / M. Righini, G. Le Gal, H. Bounameaux // Seminars inrespiratory and critical care medicine. – Thieme Medical Publishers, 2017. – Т. 38.– P. 3-10.297.
Ronsse G. Superficial femoral vein ligation and distal venous thrombectomy assurgical therapy for recent thrombophlebitis of the lower extremities. A clinicalstudy (author’s transl) / G. Ronsse, J. Stalport, D. Burnon // Acta chirurgicaBelgica. – 1980. – Т. 79. – № 4. – P. 257-263.298. Rosenthal D. OptEase retrievable inferior vena cava filter: initial multicenterexperience / D. Rosenthal [et al.] // Vascular. – 2005. – Т. 13. – № 5. – P. 286-289.299. Rosiello R.A. Timing of oral anticoagulation therapy in the treatment ofangiographically proven acute pulmonary embolism / R.A. Rosiello [et al.] //Archives of internal medicine.
– 1987. – Т. 147. – № 8. – P. 1469-1473.300. Sarosiek S. Indications, complications, and management of inferior vena cavafilters: the experience in 952 patients at an academic hospital with a level I traumacenter / S. Sarosiek, M. Crowther, J.M. Sloan // JAMA internal medicine. – 2013.– Т. 173. – № 7. – P. 513-517.317301.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
